Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug discovery process for kinase inhibitors.

× No keyword cloud information.

18 in total

1. From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Authors: Emilie Durieu; Eric Prina; Olivier Leclercq; Nassima Oumata; Nicolas Gaboriaud-Kolar; Konstantina Vougogiannopoulou; Nathalie Aulner; Audrey Defontaine; Joo Hwan No; Sandrine Ruchaud; Alexios-Leandros Skaltsounis; Hervé Galons; Gerald F Späth; Laurent Meijer; Najma Rachidi
Journal: Antimicrob Agents Chemother Date: 2016-04-22 Impact factor: 5.191

2. CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.

Authors: C Delehouzé; K Godl; N Loaëc; C Bruyère; N Desban; N Oumata; H Galons; T I Roumeliotis; E G Giannopoulou; J Grenet; D Twitchell; J Lahti; N Mouchet; M-D Galibert; S D Garbis; L Meijer
Journal: Oncogene Date: 2013-12-09 Impact factor: 9.867

3. Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening.

Authors: Michal Brylinski; Jeffrey Skolnick
Journal: J Chem Inf Model Date: 2010-10-25 Impact factor: 4.956

4. Cross-reactivity virtual profiling of the human kinome by X-react(KIN): a chemical systems biology approach.

Authors: Michal Brylinski; Jeffrey Skolnick
Journal: Mol Pharm Date: 2010-11-08 Impact factor: 4.939

5. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.

Authors: Neil Vasdev; Frank J LaRonde; James R Woodgett; Armando Garcia; Elizabeth A Rubie; Jeffrey H Meyer; Sylvain Houle; Alan A Wilson
Journal: Bioorg Med Chem Date: 2008-03-06 Impact factor: 3.641

6. Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.

Authors: Saw Simeon; Nathjanan Jongkon; Warot Chotpatiwetchkul; M Paul Gleeson
Journal: J Comput Aided Mol Des Date: 2019-09-07 Impact factor: 3.686

7. Computational study of EGFR inhibition: molecular dynamics studies on the active and inactive protein conformations.

Authors: Napat Songtawee; M Paul Gleeson; Kiattawee Choowongkomon
Journal: J Mol Model Date: 2012-09-07 Impact factor: 1.810

8. Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development.

Authors: Gaetano Romano
Journal: ISRN Oncol Date: 2013-06-06

9. Comparative amino acid decomposition analysis of potent type I p38α inhibitors.

Authors: Ahmad Ebadi; Nima Razzaghi-Asl; Mehdi Khoshneviszadeh; Ramin Miri
Journal: Daru Date: 2013-05-29 Impact factor: 3.117

10. KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms.

Authors: Yi-Yuan Chiu; Chih-Ta Lin; Jhang-Wei Huang; Kai-Cheng Hsu; Jen-Hu Tseng; Syuan-Ren You; Jinn-Moon Yang
Journal: Nucleic Acids Res Date: 2012-11-28 Impact factor: 16.971